Putnam Investments’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-3,767
Closed -$384K 1234
2023
Q2
$384K Buy
+3,767
New +$384K ﹤0.01% 1005